Floatz logo

Tetanus-Cmv Fusion Peptide Vaccine

Cytomegalovirus Infection

City of Hope Medical CentervaccinePhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

10 Active assets in the Cytomegalovirus Infection cohort.

Asset / SponsorPhaseRating
Foscarnet
City of Hope Medical Center
Phase 4BB
Valganciclovir
The Methodist Hospital Research Institute
Phase 3BB
Ganciclovir
City of Hope Medical Center
Phase 3BB
Cmvpp65-A*0201 Peptide Vaccine
City of Hope Medical Center
Phase 2B
Letermovir
Fernanda P Silveira, MD, MS
Phase 2B

View all 16 →

Same molecule, other indications

Tetanus-Cmv Fusion Peptide Vaccine is also rated in:

acute myeloid leukemiaDormant
CC
Indicative ·
47 / 100
View asset →
acute myeloid leukemia with 11q23 abnormalitiesDormant
CC
Indicative ·
47 / 100
View asset →
acute myeloid leukemia, del(5q31-q32)Dormant
CC
Indicative ·
47 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →